1242625

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

June 11, 2024

Fiscal Year

2024

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

New York, NY (United States)

Additional Details